pubmed-article:19596936 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0226896 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0205531 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C1527415 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0023324 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0053373 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0332624 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
pubmed-article:19596936 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:19596936 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:19596936 | pubmed:dateCreated | 2009-7-14 | lld:pubmed |
pubmed-article:19596936 | pubmed:abstractText | Lentinan (LNT) is an immune adjuvant medicine for advanced gastric cancer in Japan. Recently, an oral formulation of superfine dispersed lentinan (SDL) has become clinically available. To investigate the safety and effectiveness of SDL, a multi center clinical study in patients with advanced colorectal cancer was conducted. | lld:pubmed |
pubmed-article:19596936 | pubmed:language | eng | lld:pubmed |
pubmed-article:19596936 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19596936 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19596936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19596936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19596936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19596936 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19596936 | pubmed:month | Jul | lld:pubmed |
pubmed-article:19596936 | pubmed:issn | 1791-7530 | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:MatsudaKenjiK | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:HazamaShoichi... | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:OkaMasaakiM | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:SugaTetsuyaT | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:NakazawaSabur... | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:WatanabeSeiji... | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:YamamotoTatsu... | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:SugaYasuyoY | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:OhashiManabuM | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:YagiMasashiM | lld:pubmed |
pubmed-article:19596936 | pubmed:author | pubmed-author:SuzukiMichina... | lld:pubmed |
pubmed-article:19596936 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19596936 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:19596936 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19596936 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19596936 | pubmed:pagination | 2611-7 | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:meshHeading | pubmed-meshheading:19596936... | lld:pubmed |
pubmed-article:19596936 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19596936 | pubmed:articleTitle | Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. | lld:pubmed |
pubmed-article:19596936 | pubmed:affiliation | Department of Surgery II, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan. hazama@po.cc.yamaguchi-u.ac.jp | lld:pubmed |
pubmed-article:19596936 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19596936 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19596936 | pubmed:publicationType | Multicenter Study | lld:pubmed |